This website uses cookies to enhance the user experience.
S

SMERUD MEDICAL RESEARCH INTERNATIONAL AS970 913 297

Other healthcare services
Limited company
Thunes vei 2 0274 OSLO, Norge

SMERUD MEDICAL RESEARCH INTERNATIONAL AS

Home | SMERUD MEDICAL RESEARCH INTERNATIONAL AS
SMERUD, a leading CRO, offers full-service clinical solutions to biotech, pharma, med-tech & academic sponsors.

Keywords

environmental health protectioninformation servicecompanies' health servicethe hse servicemental health work

Links

Organization

Chairman of the board
Years since formation
30 years
since Feb 20, 1995
Type
Limited company
VAT registered
Yes
Number of employees
13

Ownership

Number of shares and share classes
1,100
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
95,339,773
NOK
Annual total result 2023
15,338,136
NOK
Total equity 2023
17,860,316
NOK
Last update: Nov 14, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
indirectly

Board

NameRoleShares
Chairman
100 %
indirectly
Alternate Member-

Others

NameRoleShares
B
BANG-OLSEN REVISJON AS
Auditor-
M
MGI REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
indirectly
Last update: Sep 17, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
S
SMERUD HOLDING AS
Ordinary shares
1,100
100 %

Shares owned by the SMERUD MEDICAL RESEARCH INTERNATIONAL AS

NameShare classNumber of sharesShare
B
BIONOR HOLDING AS
NO0010813736
1,275,760
2.8 %
I
INSULIFE AS
NO0012753625
1,219,512
1.76 %
I
INANOD AS
Ordinary shares
60,000
1.71 %
I
IMMUNOR AS
Ordinary shares
2,551,520
1.14 %
S
SERODUS AS
NO0010549801
26,467
0.14 %
P
PHOTOCURE ASA
NO0010000045
350
< 0.01 %
P
PCI BIOTECH HOLDING ASA
NO0010405640
35
< 0.01 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -23,825
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
95,339,773
63,455,965
37,973,563
Annual Total Result
15,338,136
5,811,649
2,191,854
Total assets
40,165,876
47,466,976
28,828,211
Total liabilities
22,305,559
34,648,742
21,821,626
Total equity
17,860,316
12,818,234
7,006,584

P&L

Year202320222021
Total operating income
95,339,773
63,455,965
37,973,563
Total operating costs
74,668,276
56,430,438
35,301,539
Operating result
20,671,497
7,025,527
2,672,024
Financial income/costs
-512,370
-1,213,877
-480,169
Profit before tax
20,159,128
5,811,649
2,191,854
Total tax & extraordinary income/cost
4,820,992
0
0
Annual Total Result
15,338,136
5,811,649
2,191,854

Balance overview

Year202320222021
Total fixed assets
4,290,897
4,431,288
450,817
Total current assets
35,874,979
43,035,688
28,377,394
Total assets
40,165,876
47,466,976
28,828,211
Short term debt
22,305,559
34,648,742
21,821,626
Long term debt
0
0
0
Total liabilities
22,305,559
34,648,742
21,821,626
Contributed capital
5,672,547
5,672,547
5,672,547
Retained earnings
12,187,769
7,145,687
1,334,037
Total equity
17,860,316
12,818,234
7,006,584
Total equity and liabilities
40,165,876
47,466,976
28,828,211

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.904
Industrial group
Other preventive health care